Cargando…
Guidelines for the Management of Sexually Transmitted Infections.
This newly revised publication provides new treatment recommendations for a comprehensive management of patients with sexually transmitted infections (STIs) in the broader context of control, prevention and care programmes for STIs and HIV. Covers both the syndromic approach to the management of pat...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Albany :
World Health Organization,
2003.
|
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- PREFACE; 1. INTRODUCTION; 1.1. Background; 1.2. Rationale for standardized treatment recommendations; 1.3. Case management; 1.4. Syndromic management; 1.5. Risk factors for STI-related cervicitis; 1.6. Selection of drugs; 2. TREATMENT OF STI-ASSOCIATED SYNDROMES; 2.1. Urethral discharge; Persistent or recurrent urethral discharge; 2.2. Genital ulcers; Genital ulcers and HIV infection; Inguinal bubo; 2.3. Scrotal swelling; 2.4. Vaginal discharge; Cervical infection; Vaginal infection; 2.5. Lower abdominal pain; 2.6. Neonatal conjunctivitis; 3. TREATMENT OF SPECIFIC INFECTIONS.
- 3.1 Gonococcal infectionsUncomplicated anogenital infection; Disseminated gonococcal infection; Gonococcal ophthalmia; 3.2 Chlamydia trachomatis infections (other than lymphogranuloma venereum); Uncomplicated anogenital infection; Chlamydial infection during pregnancy; Neonatal chlamydial conjunctivitis; Infantile pneumonia; 3.3 Lymphogranuloma venereum; 3.4 Syphilis; Clinical presentation summary; Syphilis and HIV infection; Syphilis in pregnancy; Congenital syphilis; Early syphilis; Late latent syphilis; Neurosyphilis; Congenital syphilis; 3.5 Chancroid.
- 3.6 Granuloma inguinale (Donovanosis)3.7 Genital herpes infections; Herpes in pregnancy; Herpes and HIV coinfection; Suppressive therapy; 3.8 Venereal (genital) warts; Vaginal warts; Cervical warts; Meatal and urethral warts; 3.9 Trichomonas vaginalis infections; Trichomoniasis in pregnancy; 3.10 Bacterial vaginosis; BV in pregnancy; BV and surgical procedures; 3.11 Candidiasis; Vulvo-vaginal candidiasis; Vulvo-vaginal candidiasis in pregnancy; Vulvo-vaginal candidiasis and HIV infection; Balanoposthitis; 3.12 Scabies; 3.13 Pubic lice; 4. KEY CONSIDERATIONS UNDERLYING TREATMENTS.
- 4.1 The choice of antimicrobial regimenEfficacy; Safety; Cost; Compliance and acceptability; Availability; Coexistent infections; Risk of reducing drug efficacy for other indications; 4.2 Comments on individual drugs; Cephalosporins; Macrolides; Sulphonamides; Quinolones; Tetracyclines; 4.3 Antimicrobial resistance in N. gonorrhoeae; 4.4 Antimicrobial resistance in H. ducreyi; 5. PRACTICAL CONSIDERATIONS IN STI CASE MANAGEMENT; 5.1 The public health package for STI prevention and control; 5.2 Comprehensive case management of STI; Identification of the syndrome.
- Antimicrobial treatment for the syndromeEducation of the patient; Condom supply; Counselling; Notification and management of sexual partners; 5.3 Access to services; 6. CHILDREN, ADOLESCENTS AND SEXUALLY TRANSMITTED INFECTIONS; 6.1 Evaluation for sexually transmitted infections; Initial examination; Examination at 12 weeks following assault; Presumptive treatment; Susceptibility and clinical presentation of STI in children and adolescents; Cervical infections; Genital ulcer disease; Anogenital warts; Vaginal infection; ANNEXES; ANNEX 1. LIST OF PARTICIPANTS, MAY 1999.